We are live on ! Find out more
SEC

Seven Eight Capital Portfolio holdings

AUM $1.11B
1-Year Est. Return 29.48%
This Fund
S&P 500
This Quarter Est. Return
+9.18%
1 Year Est. Return
+29.48%
3 Year Est. Return
+13.61%
5 Year Est. Return
+117.69%
10 Year Est. Return
+239.1%
AUM
$605M
AUM Growth
+$125M
Cap. Flow
+$96.3M
Cap. Flow %
15.91%
Top 10 Hldgs %
10.86%
Holding
696
New
282
Increased
102
Reduced
88
Closed
224

Top Buys

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$7.1M
2
INCY icon
Incyte
INCY
+$6.78M
3
TGT icon
Target
TGT
+$5.96M
4
RMD icon
ResMed
RMD
+$5.78M
5
MSCI icon
MSCI
MSCI
+$5.72M

Top Sells

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$46.8M
2
WYNN icon
Wynn Resorts
WYNN
+$5.62M
3
AAPL icon
Apple
AAPL
+$5.53M
4
NVS icon
Novartis
NVS
+$5.28M
5
WMT icon
Walmart Inc
WMT
+$4.64M

Sector Composition

Rank Sector Weight
1 Technology 21.66%
2 Consumer Discretionary 17.11%
3 Healthcare 16.08%
4 Industrials 11.44%
5 Financials 7.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AEL
101
DELISTED
American Equity Investment Life Holding Company
AEL
$1.86M 0.31%
35,736
+22,211
+164% +$893K
DELL icon
102
Dell
DELL
$262B
$1.86M 0.31%
34,292
+13,770
+67% +$634K
CNX icon
103
CNX Resources
CNX
$4.9B
$1.84M 0.3%
103,745
-23,795
-19% -$384K
IMGN
104
DELISTED
Immunogen Inc
IMGN
$1.83M 0.3%
+96,984
New +$1.15M
YPF icon
105
YPF
YPF
$20.4B
$1.81M 0.3%
+121,347
New +$1.47M
DVN icon
106
Devon Energy
DVN
$50.9B
$1.81M 0.3%
37,368
+22,274
+148% +$1.12M
RVNC
107
DELISTED
Revance Therapeutics, Inc.
RVNC
$1.79M 0.3%
70,697
+61,788
+694% +$1.92M
CL icon
108
Colgate-Palmolive
CL
$73.3B
$1.78M 0.29%
23,056
+7,857
+52% +$608K
RPD icon
109
Rapid7
RPD
$634M
$1.75M 0.29%
+38,643
New +$1.79M
PCAR icon
110
PACCAR
PCAR
$70.4B
$1.72M 0.28%
+20,612
New +$1.52M
FISV
111
Fiserv Inc
FISV
$28.8B
$1.72M 0.28%
+13,659
New +$1.61M
ON icon
112
ON Semiconductor
ON
$32.6B
$1.7M 0.28%
+18,023
New +$1.49M
EPAM icon
113
EPAM Systems
EPAM
$5.42B
$1.69M 0.28%
+7,520
New +$1.89M
PH icon
114
Parker-Hannifin
PH
$121B
$1.67M 0.28%
+4,293
New +$1.45M
ADM icon
115
Archer Daniels Midland
ADM
$38.9B
$1.67M 0.28%
+22,157
New +$1.68M
ZIM icon
116
ZIM Integrated Shipping Services
ZIM
$2.98B
$1.67M 0.28%
+135,024
New +$2.17M
SE icon
117
Sea Limited
SE
$65.1B
$1.66M 0.27%
+28,526
New +$2.03M
PATH icon
118
UiPath
PATH
$6.41B
$1.65M 0.27%
+99,495
New +$1.6M
RTX icon
119
RTX Corp
RTX
$289B
$1.64M 0.27%
+16,747
New +$1.64M
DLTR icon
120
Dollar Tree
DLTR
$24.7B
$1.61M 0.27%
+11,222
New +$1.65M
PENN icon
121
PENN Entertainment
PENN
$2.75B
$1.61M 0.27%
+66,946
New +$1.78M
PARA
122
DELISTED
Paramount Global Class B
PARA
$1.6M 0.26%
100,781
-150,875
-60% -$2.72M
BMY icon
123
Bristol-Myers Squibb
BMY
$132B
$1.6M 0.26%
24,944
+15,322
+159% +$1.03M
AZO icon
124
AutoZone
AZO
$49.1B
$1.58M 0.26%
635
+324
+104% +$826K
FMC icon
125
FMC
FMC
$1.48B
$1.58M 0.26%
15,105
+12,413
+461% +$1.4M
3 4
5
6 7

Similar funds

PP
Pegasus Partners Mequon, Wisconsin $1.07B AUM 32.32% 1-Year Est. Return
ECM
Ensemble Capital Management San Francisco, California $1.18B AUM 41.81% 1-Year Est. Return
GCAC
Guardian Capital Advisors (Canada) Toronto, Ontario, Canada $1.02B AUM 25.29% 1-Year Est. Return
CAM
ClariVest Asset Management San Diego, California $980M AUM 60.89% 1-Year Est. Return
D
Diversified Wilmington, Delaware $911M AUM 31% 1-Year Est. Return
GFS
GYL Financial Synergies West Hartford, Connecticut $1.33B AUM 34.46% 1-Year Est. Return
FTIS
First Trust Investment Solutions Naples, Florida $888M AUM 34.3% 1-Year Est. Return
AIA
Alera Investment Advisors Deerfield, Illinois $851M AUM 29.76% 1-Year Est. Return

Seven Eight Capital's Q2 2023 Portfolio in Review

As of Q2 2023, Seven Eight Capital held 696 positions worth $605M, up 26% from $480M the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Seven Eight Capital deployed $96.3M of net new capital in Q2 2023, opening 282 new positions and adding to 102 existing holdings. Its largest new stake was AbbVie: 48,404 shares worth $6.52M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Carvana, an estimated $4.53M trimmed.

  • Seven Eight Capital's largest Q2 2023 buy was AbbVie: 48,404 shares worth $6.52M.
  • Seven Eight Capital added most to Las Vegas Sands in Q2 2023, an estimated $4.94M increase.
  • Seven Eight Capital's biggest Q2 2023 reduction was Carvana, cutting an estimated $4.53M.
  • Seven Eight Capital fully exited State Street SPDR S&P 500 ETF Trust in Q2 2023, selling an estimated $46.8M.
  • Seven Eight Capital's ten largest holdings make up 11% of its $605M portfolio in Q2 2023.
  • Seven Eight Capital opened 282 new positions and closed 224 in Q2 2023.
  • Seven Eight Capital's portfolio value rose 26% quarter-over-quarter to $605M.

Based on Seven Eight Capital's 13F filing for Q2 2023, filed 14 Aug 2023.